• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PRECHAMBER PED.; HYDROCHEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PRECHAMBER PED.; HYDROCHEPHALUS MANAGEMENT Back to Search Results
Model Number FV035T
Device Problem Complete Blockage (1094)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/27/2020
Event Type  Injury  
Manufacturer Narrative
Manufacturing evaluation: investigation on-going.Should additional relevant information become available, a supplemental medwatch report will be provided.
 
Event Description
The complainant reported that a progav 2.0 with shunt assistance 20 (part # fx413t) (ref.Associated mdr id 3004721439-2020-00182) and prechamber (part # fv035t) were implanted in a patient on (b)(6) 2019.Reportedly, contrast medium was injected into the device, which revealed that the flow was blocked at the location of the shunt valve.The patient underwent revision surgery on (b)(6) 2020.No known patient complications.No further additional information is currently available.Associated medwatch: 3004721439-2020-00182.
 
Manufacturer Narrative
Investigation: visual inspection: the following observations were made during the visual inspection: significant deposits are visible within the reservoir.Permeability test: the test did not show any flow, because the deposits placed in front of the outlet spout and blocked the prechamber, thus preventing drainage.Results: based on our investigation, we are able to substantiate the claim of "blockage".We are assuming that the deposits detected within the prechmaber have caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.From our point of view, no further regulatory actions are required.Same patient medwatch: #3004721439-2020-00182.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECHAMBER PED.
Type of Device
HYDROCHEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
ulanenweg 2
potsdam, 14469
GM  14469
MDR Report Key10546417
MDR Text Key207333384
Report Number3004721439-2020-00183
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906117603
UDI-Public4041906117603
Combination Product (y/n)N
PMA/PMN Number
K011030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFV035T
Device Catalogue NumberFV035T
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer09/16/2020
Date Manufacturer Received09/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-